Tissuemed has announced that its TissuePatch3 patent filing has now been allowed by the Australian patent authorities and will be granted in the next few days. For Tissuemed David Mandley commented; “This patent pertains to our base terpolymer technology, so we are pleased to see it granted in what is an important territory for us”.